sec filing - novogen yale uni joint venture , page-20

I agree Moose. The partnership is not just in broad terms Novogen + Yale. Its a partnership with CS6 developed by Novogen + the delivery system developed by Yale. It's also a coupling of their combined experience in this specific area - the two heads are better than one equation.

Joining with another big pharma may have its merits but would not be able to bring the same level of synergy at this point in time.

Moose if another biotech was making this announcement surely you and I would be thinking why did Novogen miss out? Do they think that their drug is better than CS6?

Of all the drugs to test Yale's cutting edge delivery system thay have tapped us on the shoulder.

Speaks volumes.